Related Experiment Videos
[Tibolone].
Christian Jamin1, Christophe Poncelet, Patrick Madelenat
1Service de gynécologie-obstétrique CHU Bichat, 46, rue Henri Huchard 75018 Paris.
Presse Medicale (Paris, France : 1983)
|October 3, 2002
Summary
Tibolone is a precursor drug that converts into active metabolites, offering estrogenic, androgenic, and antiestrogenic effects. It effectively treats menopausal symptoms and prevents bone loss with good tolerance in healthy populations.
Area of Science:
- Endocrinology
- Pharmacology
Background:
- Tibolone (OD 14) is a synthetic steroid used for hormone replacement therapy.
- It acts as a prodrug, metabolized into active compounds with tissue-specific effects.
Purpose of the Study:
- To elucidate the indirect mechanism of action of Tibolone.
- To describe its tissue-specific metabolic pathways and resulting activities.
- To evaluate its clinical effects on menopausal symptoms and bone health.
Main Methods:
- In vivo and in vitro studies to determine Tibolone metabolism.
- Assessment of estrogenic, progestagenic, and androgenic activities in various tissues.
- Clinical evaluation of efficacy and tolerance in postmenopausal women.
Main Results:
- Tibolone metabolites exhibit estrogenic effects in the brain, genito-urinary tract, vascular endothelium, and bone.
- It demonstrates mild androgenic effects in the brain and muscle, and antiestrogenic effects in the breast.
- Tibolone positively impacts lipid profiles and fibrinolysis, treats estrogen deprivation symptoms, and prevents bone loss without inducing bleeding or mastodynia.
Conclusions:
- Tibolone's indirect mechanism involves tissue-specific metabolism to active compounds with diverse hormonal activities.
- It is effective in managing menopausal symptoms and bone loss, with excellent tolerance in healthy individuals.
- Further large-scale studies are needed to assess fracture risk, cardiovascular effects, and breast health outcomes in specific populations.